{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T13:17:02Z","timestamp":1787491022461,"version":"build-2736575974"},"reference-count":72,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"JSPS KAKENHI","award":["25K11505"],"award-info":[{"award-number":["25K11505"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>End-stage renal disease (ESRD) is a major global health burden, and current treatments, such as dialysis and kidney transplantation, remain constrained by donor shortages, procedure-related complications, and reduced long-term quality of life. Regenerative medicine, particularly stem cell-based approaches, offers promising next-generation strategies for kidney repair and replacement. This review summarizes the current understanding of kidney development and intrinsic regenerative capacity and evaluates the therapeutic potential of hematopoietic stem cells, mesenchymal stem cells (MSCs), kidney-derived stem cells, and induced pluripotent stem cell (iPSC)-derived kidney organoids. Evidence from preclinical models demonstrates renoprotective and immunomodulatory effects across multiple stem cell types, whereas early-phase clinical trials have reported favorable safety profiles and preliminary signals of the efficacy of MSC-based therapies. iPSC- and organoid-based approaches present additional challenges, including incomplete vascularization, immature nephron structures, risks of tumorigenicity, immune compatibility issues, and the need for reproducible good manufacturing practice (GMP)-compliant manufacturing. Advances in biomaterials, organoid engineering, and vascularization strategies may help overcome these barriers. Overall, stem cell-based regenerative therapies show substantial potential to complement or ultimately reduce the reliance on dialysis and transplantation. Continued technological innovations and rigorously designed clinical trials are critical to translate these promising approaches into clinical practice.<\/jats:p>","DOI":"10.1093\/stmcls\/sxag003","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:49:59Z","timestamp":1767962999000},"source":"Crossref","is-referenced-by-count":2,"title":["Stem cell and bioengineering approaches for end-stage renal disease: a comprehensive review"],"prefix":"10.1093","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4354-7690","authenticated-orcid":false,"given":"Yusuke","family":"Nishimura","sequence":"first","affiliation":[{"name":"Department of Clinical Engineering, Faculty of Medical Science and Technology, Gunma Paz University ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"2026040200051985800_sxag003-B1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1186\/s12882-025-04309-7","article-title":"Global trends of chronic kidney disease from 1990 to 2021: a systematic analysis for the global burden of disease study 2021","volume":"26","author":"Li","year":"2025","journal-title":"BMC Nephrol"},{"key":"2026040200051985800_sxag003-B2","doi-asserted-by":"crossref","first-page":"9636897231164251","DOI":"10.1177\/09636897231164251","article-title":"Mesenchymal stem cell therapy in kidney diseases: potential and challenges","volume":"32","author":"Chen","year":"2023","journal-title":"Cell Transplant"},{"key":"2026040200051985800_sxag003-B3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13287-022-02713-6","article-title":"Identification of functional pathways for regenerative bioactivity of selected renal cells","volume":"13","author":"Sha","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"2026040200051985800_sxag003-B4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/MOT.0000000000000170","article-title":"Kidney regeneration from human induced pluripotent stem cells","volume":"20","author":"Mae","year":"2015","journal-title":"Curr Opin Organ Transplant"},{"key":"2026040200051985800_sxag003-B5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/s13287-024-03992-x","article-title":"The renoprotective efficacy and safety of genetically-engineered human bone marrow-derived mesenchymal stromal cells expressing anti-fibrotic cargo","volume":"15","author":"Li","year":"2024","journal-title":"Stem Cell Res Ther"},{"key":"2026040200051985800_sxag003-B6","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.stemcr.2024.04.011","article-title":"Human pluripotent stem cell-derived kidney organoids reveal tubular epithelial pathobiology of heterozygous HNF1B-associated dysplastic kidney malformations","volume":"19","author":"Bantounas","year":"2024","journal-title":"Stem Cell Reports"},{"key":"2026040200051985800_sxag003-B7","first-page":"1","article-title":"Progress of induced pluripotent stem cell-derived renal organoids in clinical application","volume":"11","author":"Ning","year":"2025","journal-title":"Kidney Dis (Basel)"},{"key":"2026040200051985800_sxag003-B8","doi-asserted-by":"crossref","first-page":"1511525","DOI":"10.3389\/fphar.2024.1511525","article-title":"Protective effects and possible mechanisms of mesenchymal stem cells and mesenchymal stem cell-derived extracellular vesicles against kidney fibrosis in animal models: a systematic review and meta-analysis","volume":"15","author":"Lv","year":"2024","journal-title":"Front Pharmacol"},{"key":"2026040200051985800_sxag003-B9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12882-025-04029-y","article-title":"Immunomodulatory effects of mesenchymal stem cell therapy in chronic kidney disease: a literature review","volume":"26","author":"Li","year":"2025","journal-title":"BMC Nephrol"},{"key":"2026040200051985800_sxag003-B10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00109-024-02432-w","article-title":"The therapeutic effect of mesenchymal stem cells in diabetic kidney disease","volume":"102","author":"Habiba","year":"2024","journal-title":"J Mol Med (Berl)"},{"key":"2026040200051985800_sxag003-B11","doi-asserted-by":"crossref","first-page":"1505601","DOI":"10.3389\/fcell.2024.1505601","article-title":"Cell therapy in kidney diseases: advancing treatments for renal regeneration","volume":"12","author":"Salybekov","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"2026040200051985800_sxag003-B12","doi-asserted-by":"crossref","first-page":"113602","DOI":"10.1016\/j.celrep.2023.113602","article-title":"Selective induction of human renal interstitial progenitor-like cell lineages from iPSCs reveals development of mesangial and EPO-producing cells","volume":"43","author":"Tsujimoto","year":"2024","journal-title":"Cell Rep"},{"key":"2026040200051985800_sxag003-B13","doi-asserted-by":"crossref","first-page":"e4757","DOI":"10.21769\/BioProtoc.4757","article-title":"Preparation of human kidney progenitor cultures and their differentiation into podocytes","volume":"13","author":"Melica","year":"2023","journal-title":"Bio Protoc"},{"key":"2026040200051985800_sxag003-B14","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1186\/s12967-024-05575-z","article-title":"Urine-derived podocytes from steroid resistant nephrotic syndrome patients as a model for renal-progenitor derived extracellular vesicles effect and drug screening","volume":"22","author":"Tanzi","year":"2024","journal-title":"J Transl Med"},{"key":"2026040200051985800_sxag003-B15","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.34067\/KID.0000000000000543","article-title":"Origins and molecular mechanisms underlying renal vascular development","volume":"5","author":"Nishimura","year":"2024","journal-title":"Kidney360"},{"key":"2026040200051985800_sxag003-B16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41581-022-00553-4","article-title":"Mapping the human kidney using single-cell genomics","volume":"18","author":"Schreibing","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"2026040200051985800_sxag003-B17","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/emmm.201201584","article-title":"Identification of human nephron progenitors capable of generation of kidney structures and functional repair of chronic renal disease","volume":"5","author":"Harari-Steinberg","year":"2013","journal-title":"EMBO Mol Med"},{"key":"2026040200051985800_sxag003-B18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.stemcr.2017.04.026","article-title":"Evidence of In vitro preservation of human nephrogenesis at the single-cell level","volume":"9","author":"Pode-Shakked","year":"2017","journal-title":"Stem Cell Reports"},{"key":"2026040200051985800_sxag003-B19","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1038\/s44318-025-00504-2","article-title":"Human fetal kidney organoids model early human nephrogenesis and notch-driven cell fate","volume":"44","author":"Namestnikov","year":"2025","journal-title":"Embo J"},{"key":"2026040200051985800_sxag003-B20","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1007\/s11255-014-0821-z","article-title":"Progenitor\/stem cells in renal regeneration and mass lesions","volume":"46","author":"Zhang","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"2026040200051985800_sxag003-B21","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev-physiol-052521-121841","article-title":"How many cell types are in the kidney and what do they do?","volume":"84","author":"Balzer","year":"2022","journal-title":"Annu Rev Physiol"},{"key":"2026040200051985800_sxag003-B22","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.kint.2022.06.011","article-title":"Spatially resolved transcriptomics and the kidney: many opportunities","volume":"102","author":"Dixon","year":"2022","journal-title":"Kidney Int"},{"key":"2026040200051985800_sxag003-B23","first-page":"100767","article-title":"A high-definition spatiotemporal transcriptomic atlas of mammalian kidney development","volume":"6","author":"Jiang","year":"2025","journal-title":"Innovation (Camb)"},{"key":"2026040200051985800_sxag003-B24","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.celrep.2014.04.018","article-title":"In vivo clonal analysis reveals lineage-restricted progenitor characteristics in mammalian kidney development, maintenance, and regeneration","volume":"7","author":"Rinkevich","year":"2014","journal-title":"Cell Rep"},{"key":"2026040200051985800_sxag003-B25","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1073\/pnas.1310653110","article-title":"Differentiated kidney epithelial cells repair injured proximal tubule","volume":"111","author":"Kusaba","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026040200051985800_sxag003-B26","doi-asserted-by":"crossref","first-page":"eadt5553","DOI":"10.1126\/scitranslmed.adt5553","article-title":"Human iPSC-derived nephron progenitor cells treat acute kidney injury and chronic kidney disease in mouse models","volume":"17","author":"Araoka","year":"2025","journal-title":"Sci Transl Med"},{"key":"2026040200051985800_sxag003-B27","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature15695","article-title":"Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis","volume":"526","author":"Takasato","year":"2015","journal-title":"Nature"},{"key":"2026040200051985800_sxag003-B28","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/nbt.3392","article-title":"Nephron organoids derived from human pluripotent stem cells model kidney development and injury","volume":"33","author":"Morizane","year":"2015","journal-title":"Nat Biotechnol"},{"key":"2026040200051985800_sxag003-B29","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.stem.2017.10.011","article-title":"Higher-Order kidney organogenesis from pluripotent stem cells","volume":"21","author":"Taguchi","year":"2017","journal-title":"Cell Stem Cell"},{"key":"2026040200051985800_sxag003-B30","doi-asserted-by":"crossref","first-page":"F143","DOI":"10.1152\/ajprenal.00116.2025","article-title":"Kidney organoid models of polycystic kidney disease: challenges and future directions","volume":"329","author":"Afrin","year":"2025","journal-title":"Am J Physiol Renal Physiol"},{"key":"2026040200051985800_sxag003-B31","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.jcyt.2025.04.062","article-title":"Evaluating teratoma formation risk of pluripotent stem cell-derived cell therapy products: a consensus recommendation from the health and environmental sciences institute\u2019s international cell therapy committee","volume":"27","author":"Watanabe","year":"2025","journal-title":"Cytotherapy"},{"key":"2026040200051985800_sxag003-B32","doi-asserted-by":"crossref","first-page":"36","DOI":"10.7150\/ijms.21666","article-title":"Ethical and safety issues of stem cell-based therapy","volume":"15","author":"Volarevic","year":"2018","journal-title":"Int J Med Sci"},{"key":"2026040200051985800_sxag003-B33","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.kint.2024.10.028","article-title":"Challenges in maturation and integration of kidney organoids for stem cell-based renal replacement therapy","volume":"107","author":"van den Berg","year":"2025","journal-title":"Kidney Int"},{"key":"2026040200051985800_sxag003-B34","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"2026040200051985800_sxag003-B35","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.stem.2012.05.005","article-title":"Induced pluripotent stem cells: past, present, and future","volume":"10","author":"Yamanaka","year":"2012","journal-title":"Cell Stem Cell"},{"key":"2026040200051985800_sxag003-B36","doi-asserted-by":"crossref","first-page":"e1096","DOI":"10.1002\/cpz1.1096","article-title":"Protocol for the growth and maturation of hiPSC-Derived kidney organoids using mechanically defined hydrogels","volume":"4","author":"Krupa","year":"2024","journal-title":"Curr Protoc"},{"key":"2026040200051985800_sxag003-B37","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/s42003-023-05203-4","article-title":"iPSC-derived type IV collagen \u03b15-expressing kidney organoids model alport syndrome","volume":"6","author":"Hirayama","year":"2023","journal-title":"Commun Biol"},{"key":"2026040200051985800_sxag003-B38","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.stem.2022.06.005","article-title":"A scalable organoid model of human autosomal dominant polycystic kidney disease for disease mechanism and drug discovery","volume":"29","author":"Tran","year":"2022","journal-title":"Cell Stem Cell"},{"key":"2026040200051985800_sxag003-B39","doi-asserted-by":"crossref","first-page":"eabq0866","DOI":"10.1126\/sciadv.abq0866","article-title":"Organoid-on-a-chip model of human ARPKD reveals mechanosensing pathomechanisms for drug discovery","volume":"8","author":"Hiratsuka","year":"2022","journal-title":"Sci Adv"},{"key":"2026040200051985800_sxag003-B40","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.kint.2024.05.026","article-title":"A genetically inducible endothelial niche enables vascularization of human kidney organoids with multilineage maturation and emergence of renin expressing cells","volume":"106","author":"Maggiore","year":"2024","journal-title":"Kidney Int"},{"key":"2026040200051985800_sxag003-B41","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s13287-023-03528-9","article-title":"HIF-1\u03b1 promotes kidney organoid vascularization and applications in disease modeling","volume":"14","author":"Peng","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"2026040200051985800_sxag003-B42","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/stmcls\/sxac009","article-title":"Kidney organoids are capable of forming tumors, but not teratomas","volume":"40","author":"Shankar","year":"2022","journal-title":"Stem Cells"},{"key":"2026040200051985800_sxag003-B43","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1634\/stemcells.2006-0394","article-title":"Identification of common pathways mediating differentiation of bone marrow- and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages","volume":"25","author":"Liu","year":"2007","journal-title":"Stem Cells"},{"key":"2026040200051985800_sxag003-B44","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s43465-024-01239-8","article-title":"Chondrogenic potential of umbilical cord-derived mesenchymal stromal cells: insights and innovations","volume":"58","author":"Jeyaraman","year":"2024","journal-title":"Indian J Orthop"},{"key":"2026040200051985800_sxag003-B45","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2174\/1574888X18666230206115046","article-title":"The beneficial effects of mesenchymal stem cells in acute kidney injury: a narrative review","volume":"19","author":"Liu","year":"2024","journal-title":"Curr Stem Cell Res Ther"},{"key":"2026040200051985800_sxag003-B46","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.3390\/cells9081805","article-title":"PKHhigh\/CD133+\/CD24- renal stem-like cells isolated from human nephrospheres exhibit In vitro multipotency","volume":"9","author":"Bombelli","year":"2020","journal-title":"Cells"},{"key":"2026040200051985800_sxag003-B47","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1002\/stem.1424","article-title":"Multipotential differentiation of human urine-derived stem cells: potential for therapeutic applications in urology","volume":"31","author":"Bharadwaj","year":"2013","journal-title":"Stem Cells"},{"key":"2026040200051985800_sxag003-B48","doi-asserted-by":"crossref","first-page":"e27306","DOI":"10.1016\/j.heliyon.2024.e27306","article-title":"Urine-derived stem cells: promising advancements and applications in regenerative medicine and beyond","volume":"10","author":"Sun","year":"2024","journal-title":"Heliyon"},{"key":"2026040200051985800_sxag003-B49","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ydbio.2021.04.009","article-title":"Vascular deficiencies in renal organoids and ex vivo kidney organogenesis","volume":"477","author":"Ryan","year":"2021","journal-title":"Dev Biol"},{"key":"2026040200051985800_sxag003-B50","doi-asserted-by":"crossref","first-page":"F625","DOI":"10.1152\/ajprenal.00400.2021","article-title":"Physiology assays in human kidney organoids","volume":"322","author":"Freedman","year":"2022","journal-title":"Am J Physiol Renal Physiol"},{"key":"2026040200051985800_sxag003-B51","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41536-025-00418-x","article-title":"Single cell transcriptomics of human kidney organoid endothelium reveals vessel growth processes and arterial maturation upon transplantation","volume":"10","author":"Koning","year":"2025","journal-title":"NPJ Regen Med"},{"key":"2026040200051985800_sxag003-B52","first-page":"142","article-title":"Growth and differentiation of human induced pluripotent stem cell (hiPSC)-derived kidney organoids using fully synthetic peptide hydrogels","volume":"21","author":"Treacy","year":"2023","journal-title":"Bioact Mater"},{"key":"2026040200051985800_sxag003-B53","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.stem.2024.04.002","article-title":"Long-term expandable mouse and human-induced nephron progenitor cells enable kidney organoid maturation and modeling of plasticity and disease","volume":"31","author":"Huang","year":"2024","journal-title":"Cell Stem Cell"},{"key":"2026040200051985800_sxag003-B54","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1681\/ASN.2019050508","article-title":"Successful introduction of human renovascular units into the mammalian kidney","volume":"31","author":"Pleniceanu","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"2026040200051985800_sxag003-B55","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1080\/17460441.2023.2234280","article-title":"3D bioprinting for organ and organoid models and disease modeling","volume":"18","author":"Juraski","year":"2023","journal-title":"Expert Opin Drug Discov"},{"key":"2026040200051985800_sxag003-B56","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10047-022-01366-9","article-title":"Current status and future prospects of decellularized kidney tissue","volume":"26","author":"Nishimura","year":"2023","journal-title":"J Artif Organs"},{"key":"2026040200051985800_sxag003-B57","doi-asserted-by":"crossref","first-page":"110760","DOI":"10.1016\/j.isci.2024.110760","article-title":"Efficient proximal tubule-on-chip model from hiPSC-derived kidney organoids for functional analysis of renal transporters","volume":"27","author":"Ma","year":"2024","journal-title":"iScience"},{"key":"2026040200051985800_sxag003-B58","doi-asserted-by":"crossref","first-page":"e2305322120","DOI":"10.1073\/pnas.2305322120","article-title":"Immune-infiltrated kidney organoid-on-chip model for assessing T cell bispecific antibodies","volume":"120","author":"Kroll","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026040200051985800_sxag003-B59","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s13287-020-01852-y","article-title":"Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis","volume":"11","author":"Xiang","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"2026040200051985800_sxag003-B60","doi-asserted-by":"crossref","first-page":"20287","DOI":"10.1038\/srep20287","article-title":"Enhanced renoprotective effect of IGF-1 modified human umbilical cord-derived mesenchymal stem cells on gentamicin-induced acute kidney injury","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"},{"key":"2026040200051985800_sxag003-B61","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13287-020-01642-6","article-title":"Hypoxia-preconditioned mesenchymal stem cells prevent renal fibrosis and inflammation in ischemia-reperfusion rats","volume":"11","author":"Ishiuchi","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"2026040200051985800_sxag003-B62","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/mt.2016.90","article-title":"Mesenchymal stem cells deliver exogenous MicroRNA-let7c via exosomes to attenuate renal fibrosis","volume":"24","author":"Wang","year":"2016","journal-title":"Mol Ther"},{"key":"2026040200051985800_sxag003-B63","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.celrep.2019.12.047","article-title":"Ex vivo expanded 3D human kidney spheres engraft long term and repair chronic renal injury in mice","volume":"30","author":"Harari-Steinberg","year":"2020","journal-title":"Cell Rep"},{"key":"2026040200051985800_sxag003-B64","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1186\/s13287-024-04041-3","article-title":"MSCs-derived HGF alleviates senescence by inhibiting unopposed mitochondrial fusion-based elongation in post-acute kidney injury","volume":"15","author":"Zhuang","year":"2024","journal-title":"Stem Cell Res Ther"},{"key":"2026040200051985800_sxag003-B65","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13287-024-03647-x","article-title":"Amelioration of diabetic nephropathy in mice by a single intravenous injection of human mesenchymal stromal cells at early and later disease stages is associated with restoration of autophagy","volume":"15","author":"He","year":"2024","journal-title":"Stem Cell Res Ther"},{"key":"2026040200051985800_sxag003-B66","doi-asserted-by":"crossref","first-page":"e047622","DOI":"10.1136\/bmjopen-2020-047622","article-title":"Efficacy of umbilical cord mesenchymal stem cell transfusion for the treatment of severe AKI: a protocol for a randomised controlled trial","volume":"12","author":"Yang","year":"2022","journal-title":"BMJ Open"},{"key":"2026040200051985800_sxag003-B67","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1681\/ASN.0000000000000189","article-title":"Safety and preliminary efficacy of mesenchymal stromal cell (ORBCEL-M) therapy in diabetic kidney disease: a randomized clinical trial (NEPHSTROM)","volume":"34","author":"Perico","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"2026040200051985800_sxag003-B68","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1111\/jcmm.17310","article-title":"Allogeneic adipose tissue-derived stem cells ELIXCYTE\u00ae in chronic kidney disease: a phase I study assessing safety and clinical feasibility","volume":"26","author":"Zheng","year":"2022","journal-title":"J Cell Mol Med"},{"key":"2026040200051985800_sxag003-B69","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.kint.2019.11.022","article-title":"In a phase 1a escalating clinical trial, autologous mesenchymal stem cell infusion for renovascular disease increases blood flow and the glomerular filtration rate while reducing inflammatory biomarkers and blood pressure","volume":"97","author":"Abumoawad","year":"2020","journal-title":"Kidney Int"},{"key":"2026040200051985800_sxag003-B70","doi-asserted-by":"crossref","first-page":"10615","DOI":"10.3390\/ijms251910615","article-title":"Hydrogel-mediated local delivery of induced nephron progenitor cell-sourced molecules as a cell-free approach for acute kidney injury","volume":"25","author":"Park","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2026040200051985800_sxag003-B71","doi-asserted-by":"crossref","first-page":"e2500301","DOI":"10.1002\/adhm.202500301","article-title":"Organoid vascularization: strategies and applications","volume":"14","author":"Gao","year":"2025","journal-title":"Adv Healthc Mater"},{"key":"2026040200051985800_sxag003-B72","doi-asserted-by":"crossref","first-page":"e18422","DOI":"10.7717\/peerj.18422","article-title":"Trends and challenges in organoid modeling and expansion with pluripotent stem cells and somatic tissue","volume":"12","author":"Ge","year":"2024","journal-title":"PeerJ"}],"container-title":["Stem Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/stmcls\/advance-article-pdf\/doi\/10.1093\/stmcls\/sxag003\/66492716\/sxag003.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stmcls\/article-pdf\/44\/4\/sxag003\/66492716\/sxag003.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stmcls\/article-pdf\/44\/4\/sxag003\/66492716\/sxag003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T04:05:34Z","timestamp":1775102734000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stmcls\/article\/doi\/10.1093\/stmcls\/sxag003\/8432920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,3,26]]}},"URL":"https:\/\/doi.org\/10.1093\/stmcls\/sxag003","relation":{},"ISSN":["1066-5099","1549-4918"],"issn-type":[{"value":"1066-5099","type":"print"},{"value":"1549-4918","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,1,12]]},"article-number":"sxag003"}}